Private healthcare in the UK entered 2026 with record activity and a more experienced self pay audience. Patients increasingly compare providers digitally, but the buying decision remains unusually dependent on trust, transparent pricing, clinician credibility, service availability and confidence that the provider can handle the complete pathway.
WLW FUTURE reviewed the latest PHIN market data, NHS England referral to treatment statistics and current CQC guidance on choosing care and fees. The strongest commercial opportunity sits in matching growing demand with a customer journey that makes cost, clinical ownership, availability and next steps clear before the patient is asked to commit.
953kreported private hospital and clinic admissions across the UK in 2025
670kprivate admissions funded by medical insurance in 2025
283kprivate admissions funded by self pay in 2025
7.3mNHS RTT pathways waiting to start treatment at the end of May 2026
Research boundary
PHIN admissions cover in patient and day case activity reported by private hospitals and clinics. NHS RTT figures measure pathways rather than unique people. The two datasets should be read as separate indicators of private market scale and public waiting pressure.
PHIN admissions cover in patient and day case activity reported by private hospitals and clinics. NHS RTT figures measure pathways rather than unique people. The two datasets should be read as separate indicators of private market scale and public waiting pressure.
The headline findings for private healthcare marketing in 2026
Private admissions are at record levels
PHIN reported 953,000 UK private admissions in 2025, the fourth successive record year. Insurance funded admissions reached a new high and self pay remained close to its previous record.
NHS waiting pressure remains commercially relevant
At the end of May 2026 there were 7.3 million RTT pathways waiting to start treatment in England and around 6.2 million unique patients were estimated within that total.
Pricing clarity is part of regulated service delivery
CQC Regulation 19 requires people paying for care to receive written information on terms, payment and expected costs before treatment where reasonably practicable.
Trust signals should appear before the booking form
CQC encourages patients to use inspection information and other evidence when choosing care. Digital journeys should make provider, clinician and service credibility visible where decisions are being made.
Availability is now a conversion feature
Patients comparing private care often arrive with an immediate problem. Waiting time, appointment availability and clarity about the next step can be as important as brand awareness.
One generic funnel is rarely enough
Diagnostics, private GP, orthopaedics, mental health and elective surgery have different research journeys, price structures and conversion events.
The private healthcare market reached another record in 2025
PHIN’s June 2026 market update reported 953,000 private hospital and clinic admissions in 2025, 1% above 2024 and a fourth successive annual record. Insured admissions reached around 670,000 while self pay reached around 283,000. PHIN also reported nearly 13,400 active consultants in private healthcare during 2025. PHIN June 2026
Growth is not evenly distributed, so national marketing needs local intelligence
PHIN reported different insured and self pay patterns by nation and English region.
NHS waiting pressure continues to shape private patient intent
NHS England reported 7.3 million referral to treatment pathways waiting to start treatment at the end of May 2026. The number of unique patients was estimated at around 6.2 million. Only 65.6% of pathways were within 18 weeks against the 92% constitutional standard and 104,734 pathways had waited more than 52 weeks. NHS England May 2026
This does not mean every person on an NHS pathway will buy private care. It creates a large pool of people researching alternatives, second opinions, diagnostics, faster access and the cost of self funded treatment.
Interactive private patient acquisition checker
Check the commercial friction before buying more media
This tool screens common private healthcare customer journey problems. It is designed around conversion, transparency and trust rather than certifying clinical or regulatory compliance.
1. What is the main service?
2. How is pricing presented?
3. What is visible before booking?
4. How does the user book?
Lower friction starting point
Keep the service, pricing and booking route aligned
The current choices give patients useful information before commitment.
Pricing and transparency should be designed into the journey
CQC Regulation 19 requires providers to tell self paying users about terms, payment and expected costs in writing before services begin where reasonably practicable. If a fixed price cannot be given, CQC guidance says providers should give a written estimate including likely additional costs. CQC Regulation 19
Show useful price context
Use fixed prices where possible and ranges or examples where final cost genuinely depends on clinical need.
Explain likely extras
Consultation, diagnostics, hospital, anaesthetic and follow up costs should not appear as surprises late in the journey.
Put finance after clarity
Payment flexibility can widen access, but finance should support an understood service rather than replace service information.
Trust and provider credibility are part of patient acquisition
CQC’s current help choosing care pages encourage people to use inspection reports and service information when deciding where to receive care. Private healthcare websites should therefore make regulated provider identity, clinician details, relevant registrations, treatment location and escalation routes easy to find. CQC choosing care
1. NeedThe patient searches around a symptom, wait, procedure, specialist or need for faster diagnosis.
2. ComparePrice, location, availability, clinician credibility and the service pathway shape the shortlist.
3. ReassureProvider regulation, consultant information, expected cost and what happens next reduce uncertainty.
4. BookThe patient chooses an online, telephone or assisted route which matches the complexity of the service.
5. ContinueConfirmation, preparation, results, treatment and follow up maintain the relationship beyond the first booking.
Paid media can create demand quickly, but health targeting needs restraint
Private healthcare providers can usually advertise general services subject to normal advertising, professional and sector rules. Paid media becomes more sensitive when audience targeting uses or infers health conditions. Google treats health as a sensitive interest for personalised advertising and other platforms also restrict sensitive health targeting.
Patient data and CRM need separation between care and marketing
Private healthcare journeys collect appointment reasons, symptoms, diagnoses, treatment information and test results. ICO guidance treats health information as special category data. Using it for direct marketing or profiling can require explicit consent as well as an appropriate lawful basis. ICO direct marketing guidance
The strongest private patient journey removes uncertainty before asking for commitment
Build service specific landing pages
Private GP, MRI, dermatology and orthopaedics should not be forced through one generic conversion template.
Use local availability
Location, travel, consultant availability and appointment timing should be visible for high intent searches.
Make clinical ownership human
Named clinicians and clear responsibilities reduce the faceless feeling common in healthcare acquisition.
Measure booked and treated patients
Lead volume is not enough. Track qualified appointments, attendance, treatment conversion and lifetime value.
Benchmark your current private healthcare digital setup
Current benchmark score
0/10
Start with the patient decision journey
Connect demand, pricing, provider trust, booking, patient data and commercial measurement before increasing acquisition spend.
Where private healthcare growth remains
Own waiting time intent
Build service pages around speed, availability and what a private route can realistically deliver.
Use price clarity as conversion content
Useful cost information can qualify demand before the sales or booking team gets involved.
Win local search
Connect consultant expertise, locations, service pages and Google Business Profile activity.
Improve booking architecture
Give high intent users the shortest appropriate route to an appointment.
Connect media to patient value
Measure booked patients, attendance, treatment and revenue by source.
Build AI citation readiness
Publish clear service definitions, clinician reviewed information and evidence which AI systems can understand.
Existing WLW private healthcare research
WLW FUTURE private healthcare digital opportunity review
See where your patient journey is losing demand
WLW FUTURE can review your service architecture, search and AI visibility, paid media, pricing, trust signals, booking, CRM and conversion performance together.
Request a private healthcare digital opportunity reviewFrequently asked questions
How large is the UK private hospital market in 2026?
PHIN reported 953,000 private hospital and clinic admissions in 2025, the latest complete year available in its June 2026 update.
How many private admissions are self pay?
PHIN reported around 283,000 self pay admissions in 2025 and around 670,000 insurance funded admissions.
Do private providers need to show prices?
CQC Regulation 19 requires self paying users to receive written information about terms and expected costs before care begins where reasonably practicable.
Why does NHS waiting data matter to private healthcare marketing?
It is an indicator of the number of people experiencing delayed public treatment and researching alternatives. It does not mean every person on a waiting pathway will choose private care.
Sources and methodology
- PHIN Private healthcare market update, June 2026.
- NHS England RTT waiting times, May 2026.
- CQC Regulation 19: Fees.
- CQC help choosing care.
- ICO direct marketing guidance.
Commercial methodology: The acquisition checker and benchmark are WLW FUTURE planning tools. They do not certify clinical or regulatory compliance.
